search
Back to results

Therapeutic Education Strategy for Patients With Acute Heart Failure (EduStra-HF)

Primary Purpose

Heart Failure

Status
Active
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Therapeutic education
Sponsored by
Resicard
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Heart Failure focused on measuring Heart Failure, Therapeutic education, Quality of life

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult patient with acute HF
  • Affiliated to the French Social Security system
  • Accepting the principle of telephone monitoring
  • Accepting home visits from a study nurse
  • Possession of a mobile phone

Exclusion Criteria:

Psychosocial:

  • Refusal to accept the study design
  • Patient under guardianship
  • Monitoring obstacle: language, cognitive deficiency, itinerant lifestyle, regular travel, institutionalization
  • Inability to sign the consent form or to complete questionnaires

Medical:

  • Active cancer
  • Severe psychiatric or neurological disorder
  • Complicated acute myocardial infarction
  • Significant valvular diseases requiring surgery
  • Hypertrophic obstructive cardiomyopathy
  • Planned heart transplant
  • Cardiac surgery in the previous 3 months
  • Enrollment in another clinical trial
  • Medical or surgical procedure which might interfere with monitoring

Sites / Locations

  • Clinique Ambroise Paré
  • Clinique du Mont Louis
  • Hopital AP-HP Saint-Antoine
  • Institut Mutualiste Montsouris
  • Centre Cardiologique du Nord
  • Centre Hospitalier André Mignot

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

"Usual care"

Interventional

Arm Description

Patients will attend an appointment with the therapeutic education nurse before discharge, after which they will have no further contact with the education team. The Research team members will telephone the patient three times during the year (after 2, 6 and 12 months) to collect data on HF treatments, blood tests results, health-related events and hospitalizations.

Before discharge, patients will attend an appointment with a nurse trained in therapeutic education, in which the nurse will evaluate the overall knowledge and the skills of the patient about HF. The nurse will then define specific educational objectives with the patient, based on the patient's medical history, state of disease, comorbidities, alarm signs, fears and knowledge. Each patient will receive six telephone calls and two home-visits during the 1 year of follow-up. Each contact between the nurse and the patient will be dedicated to HF education. The patient will also receive regular short text messages containing health advice and appointment reminders. To help the patient regain his/her autonomy, intervals between education sessions will be progressively longer.

Outcomes

Primary Outcome Measures

Number of rehospitalizations for acute heart failure (HF) in both groups of patients

Secondary Outcome Measures

Patients knowledge about the illness
Nurses will evaluate during each telephone call and home visit patients knowledge and skills about the following items : illness, treatments, diet, physical activity, medical follow-up. This data will be recorded in a specific table and classified into "acquired / partially acquired / not acquired" items.
Global quality of life
Assessed by validated questionnaire SF-12
Quality of life linked to Heart Failure
Assessed by validated questionnaire KCCQ-15
Length of stay for HF and all-cause hospitalizations
Hospitalization rate for cardiovascular diseases except HF
Cardiovascular and all-cause mortality rate
B-type natriuretic peptide (BNP) or NT pro-BNP levels

Full Information

First Posted
December 5, 2016
Last Updated
October 13, 2023
Sponsor
Resicard
Collaborators
Agence Regionale de Sante d'Ile de France, Assistance Publique - Hôpitaux de Paris, French Cardiology Society, Novartis
search

1. Study Identification

Unique Protocol Identification Number
NCT03035123
Brief Title
Therapeutic Education Strategy for Patients With Acute Heart Failure
Acronym
EduStra-HF
Official Title
Impact of an Intensive Therapeutic Education on Occurrence of Clinical Events in Patients With Acute Heart Failure: EduStra-HF Study
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
April 1, 2017 (Actual)
Primary Completion Date
December 30, 2023 (Anticipated)
Study Completion Date
September 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Resicard
Collaborators
Agence Regionale de Sante d'Ile de France, Assistance Publique - Hôpitaux de Paris, French Cardiology Society, Novartis

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The EduStra-HF study will examine the impact of an intensive therapeutic education on patients discharged from hospital after an episode of acute heart failure (HF). Patients will be randomized into two groups: one will receive "usual care" monitoring and one will receive a specific educational monitoring programme for 1 year. All patients will meet with a specialized therapeutic education nurse before discharge. The effect of the intensive education on HF rehospitalization and quality of life will be examined.
Detailed Description
The prevalence of HF in France is increasing. According to a report from the Haute Autorité de Santé (HAS) - the French Health Authority - published in June 2015 concerning discharge of patients hospitalized for HF, 2.3% of the French adult population is affected. Despite improvements in treatment and HF-specific care, the rehospitalization rate for HF remains substantial, and HF management is a major public health issue. Chronic HF leads to psychological and physiological issues in patients. Furthermore, this disease affects patient quality of life and activities of daily living. The HAS also reported that even if iterative hospitalizations are the consequence of complicated and multifactorial situations, some could be prevented by improved patient care. The aim of the EduStra-HF study is to examine the effect of an intensive therapeutic education on patients discharged from hospital after an episode of acute HF. It will study whether this intervention reduces the rate of rehospitalization and increases quality of life in this population. To achieve this goal, a multicentre, randomized, two parallel arm study will be conducted. Patients will be included in several cardiology centres in Paris (Ile-de-France) over 2 years and 3 months. Included patients, chosen from patients admitted for acute HF in the participating hospitals, will be randomized into two groups, which will determine the monitoring they receive after discharge. For each patient, monitoring will last for 1 year from the day they return home. The first group of patients will be randomized to receive "usual care" monitoring and will not be given specific therapeutic education after discharge. The second group (intervention arm) will receive a specific educational monitoring programme from nurses via telephone calls and home visits, for 1 year. Monitoring will began early after discharge. Annual medical monitoring and visits to the cardiologist will also be planned. All patients, regardless of attribution arm, will meet a nurse trained in therapeutic education during their stay in hospital. Moreover, validated and HF-related self-assessed questionnaires will be analyzed to assess quality of life and impact of HF on patient activities of daily living. In the interventional arm, patients will receive monitoring documents, such as a HF information booklet and a personal monitoring agenda. The EduStra-HF study will provide a specific analysis of a multisupport therapeutic education (including medical monitoring). Data on all HF drug treatments, including the more recent ones (e.g. Entresto), blood tests results, and cardiologic data will be recorded.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure
Keywords
Heart Failure, Therapeutic education, Quality of life

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
318 (Actual)

8. Arms, Groups, and Interventions

Arm Title
"Usual care"
Arm Type
No Intervention
Arm Description
Patients will attend an appointment with the therapeutic education nurse before discharge, after which they will have no further contact with the education team. The Research team members will telephone the patient three times during the year (after 2, 6 and 12 months) to collect data on HF treatments, blood tests results, health-related events and hospitalizations.
Arm Title
Interventional
Arm Type
Experimental
Arm Description
Before discharge, patients will attend an appointment with a nurse trained in therapeutic education, in which the nurse will evaluate the overall knowledge and the skills of the patient about HF. The nurse will then define specific educational objectives with the patient, based on the patient's medical history, state of disease, comorbidities, alarm signs, fears and knowledge. Each patient will receive six telephone calls and two home-visits during the 1 year of follow-up. Each contact between the nurse and the patient will be dedicated to HF education. The patient will also receive regular short text messages containing health advice and appointment reminders. To help the patient regain his/her autonomy, intervals between education sessions will be progressively longer.
Intervention Type
Behavioral
Intervention Name(s)
Therapeutic education
Intervention Description
Interventional arm
Primary Outcome Measure Information:
Title
Number of rehospitalizations for acute heart failure (HF) in both groups of patients
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Patients knowledge about the illness
Description
Nurses will evaluate during each telephone call and home visit patients knowledge and skills about the following items : illness, treatments, diet, physical activity, medical follow-up. This data will be recorded in a specific table and classified into "acquired / partially acquired / not acquired" items.
Time Frame
1 year
Title
Global quality of life
Description
Assessed by validated questionnaire SF-12
Time Frame
1 year
Title
Quality of life linked to Heart Failure
Description
Assessed by validated questionnaire KCCQ-15
Time Frame
1 year
Title
Length of stay for HF and all-cause hospitalizations
Time Frame
1 year of follow-up
Title
Hospitalization rate for cardiovascular diseases except HF
Time Frame
1 year of follow-up
Title
Cardiovascular and all-cause mortality rate
Time Frame
1 year of follow-up
Title
B-type natriuretic peptide (BNP) or NT pro-BNP levels
Time Frame
During 1 year of follow-up
Other Pre-specified Outcome Measures:
Title
Cost effectiveness of the intervention
Description
Comparison between both groups of patients of the HF-hospitalizations average cost, related to the operating cost of the EduStra-HF method.
Time Frame
During 1 year of follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patient with acute HF Affiliated to the French Social Security system Accepting the principle of telephone monitoring Accepting home visits from a study nurse Possession of a mobile phone Exclusion Criteria: Psychosocial: Refusal to accept the study design Patient under guardianship Monitoring obstacle: language, cognitive deficiency, itinerant lifestyle, regular travel, institutionalization Inability to sign the consent form or to complete questionnaires Medical: Active cancer Severe psychiatric or neurological disorder Complicated acute myocardial infarction Significant valvular diseases requiring surgery Hypertrophic obstructive cardiomyopathy Planned heart transplant Cardiac surgery in the previous 3 months Enrollment in another clinical trial Medical or surgical procedure which might interfere with monitoring
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ariel Cohen, MD PhD
Organizational Affiliation
Hôpital Saint-Antoine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Clinique Ambroise Paré
City
Neuilly-sur-Seine
ZIP/Postal Code
92200
Country
France
Facility Name
Clinique du Mont Louis
City
Paris
ZIP/Postal Code
75011
Country
France
Facility Name
Hopital AP-HP Saint-Antoine
City
Paris
ZIP/Postal Code
75012
Country
France
Facility Name
Institut Mutualiste Montsouris
City
Paris
ZIP/Postal Code
75014
Country
France
Facility Name
Centre Cardiologique du Nord
City
Saint Denis
ZIP/Postal Code
93200
Country
France
Facility Name
Centre Hospitalier André Mignot
City
Versailles
ZIP/Postal Code
78000
Country
France

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
Sharing Individual Participant Data requires a specific authorization from the French Board CNIL (Commission Nationale de l'Informatique et des Libertés) which chooses whether to allow the research team to share patient data. A specific request is needed and will be sent to that authority.
Links:
URL
http://www.has-sante.fr/portail/upload/docs/application/pdf/2015-06/note_methodo_synthese_documentaire_ic_web.pdf
Description
Haute Autorité de Santé (HAS). Note méthodologique et de synthèse documentaire : Comment organiser la sortie des patients hospitalisés pour insuffisance cardiaque ? Points clés - Organisation des parcours. April 2015 - Accessed on 1 December 2016

Learn more about this trial

Therapeutic Education Strategy for Patients With Acute Heart Failure

We'll reach out to this number within 24 hrs